Redness and Dry Eye Relief
NDC 55651-620, Glycerin, Naphazoline hydrochloride, solution, from KC Pharmaceuticals, Inc.
- Product NDC
- 55651-620
- Status
- Listed
- Labeler
- KC Pharmaceuticals, Inc
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M018
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55651-620 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCERIN.25 g/100mL
- NAPHAZOLINE HYDROCHLORIDE.012 g/100mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55651-620-01 | 55651062001 | 1 BOTTLE in 1 BOX (55651-620-01) / 15 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55651-620 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55651-620 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55651-620. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.